[email protected] (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
2021-2027 Global and Regional NGS-based RNA-sequencing Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report Standard Version

2021-2027 Global and Regional NGS-based RNA-sequencing Industry Production, Sales and...

Home / Categories / Healthcare
2021-2027 Global and Regional NGS-based RNA-sequencing Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report Standard Version
2021-2027 Global and Regional NGS-based...
Report Code
RO1/129/55924

Publish Date
26/Feb/2021

Pages
168
PRICE
$ 3500/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5250/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 7000/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global NGS-based RNA-sequencing Market Size Analysis from 2022 to 2027

1.5.1 Global NGS-based RNA-sequencing Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global NGS-based RNA-sequencing Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global NGS-based RNA-sequencing Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: NGS-based RNA-sequencing Industry Impact

Chapter 2 Global NGS-based RNA-sequencing Competition by Types, Applications, and Top Regions and Countries

2.1 Global NGS-based RNA-sequencing (Volume and Value) by Type

2.1.1 Global NGS-based RNA-sequencing Consumption and Market Share by Type (2016-2021)

2.1.2 Global NGS-based RNA-sequencing Revenue and Market Share by Type (2016-2021)

2.2 Global NGS-based RNA-sequencing (Volume and Value) by Application

2.2.1 Global NGS-based RNA-sequencing Consumption and Market Share by Application (2016-2021)

2.2.2 Global NGS-based RNA-sequencing Revenue and Market Share by Application (2016-2021)

2.3 Global NGS-based RNA-sequencing (Volume and Value) by Regions

2.3.1 Global NGS-based RNA-sequencing Consumption and Market Share by Regions (2016-2021)

2.3.2 Global NGS-based RNA-sequencing Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global NGS-based RNA-sequencing Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global NGS-based RNA-sequencing Consumption by Regions (2016-2021)

4.2 North America NGS-based RNA-sequencing Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia NGS-based RNA-sequencing Sales, Consumption, Export, Import (2016-2021)

4.4 Europe NGS-based RNA-sequencing Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia NGS-based RNA-sequencing Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia NGS-based RNA-sequencing Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East NGS-based RNA-sequencing Sales, Consumption, Export, Import (2016-2021)

4.8 Africa NGS-based RNA-sequencing Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania NGS-based RNA-sequencing Sales, Consumption, Export, Import (2016-2021)

4.10 South America NGS-based RNA-sequencing Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America NGS-based RNA-sequencing Market Analysis

5.1 North America NGS-based RNA-sequencing Consumption and Value Analysis

5.1.1 North America NGS-based RNA-sequencing Market Under COVID-19

5.2 North America NGS-based RNA-sequencing Consumption Volume by Types

5.3 North America NGS-based RNA-sequencing Consumption Structure by Application

5.4 North America NGS-based RNA-sequencing Consumption by Top Countries

5.4.1 United States NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

5.4.2 Canada NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

5.4.3 Mexico NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

Chapter 6 East Asia NGS-based RNA-sequencing Market Analysis

6.1 East Asia NGS-based RNA-sequencing Consumption and Value Analysis

6.1.1 East Asia NGS-based RNA-sequencing Market Under COVID-19

6.2 East Asia NGS-based RNA-sequencing Consumption Volume by Types

6.3 East Asia NGS-based RNA-sequencing Consumption Structure by Application

6.4 East Asia NGS-based RNA-sequencing Consumption by Top Countries

6.4.1 China NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

6.4.2 Japan NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

6.4.3 South Korea NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

Chapter 7 Europe NGS-based RNA-sequencing Market Analysis

7.1 Europe NGS-based RNA-sequencing Consumption and Value Analysis

7.1.1 Europe NGS-based RNA-sequencing Market Under COVID-19

7.2 Europe NGS-based RNA-sequencing Consumption Volume by Types

7.3 Europe NGS-based RNA-sequencing Consumption Structure by Application

7.4 Europe NGS-based RNA-sequencing Consumption by Top Countries

7.4.1 Germany NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

7.4.2 UK NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

7.4.3 France NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

7.4.4 Italy NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

7.4.5 Russia NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

7.4.6 Spain NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

7.4.7 Netherlands NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

7.4.8 Switzerland NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

7.4.9 Poland NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

Chapter 8 South Asia NGS-based RNA-sequencing Market Analysis

8.1 South Asia NGS-based RNA-sequencing Consumption and Value Analysis

8.1.1 South Asia NGS-based RNA-sequencing Market Under COVID-19

8.2 South Asia NGS-based RNA-sequencing Consumption Volume by Types

8.3 South Asia NGS-based RNA-sequencing Consumption Structure by Application

8.4 South Asia NGS-based RNA-sequencing Consumption by Top Countries

8.4.1 India NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

8.4.2 Pakistan NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

8.4.3 Bangladesh NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia NGS-based RNA-sequencing Market Analysis

9.1 Southeast Asia NGS-based RNA-sequencing Consumption and Value Analysis

9.1.1 Southeast Asia NGS-based RNA-sequencing Market Under COVID-19

9.2 Southeast Asia NGS-based RNA-sequencing Consumption Volume by Types

9.3 Southeast Asia NGS-based RNA-sequencing Consumption Structure by Application

9.4 Southeast Asia NGS-based RNA-sequencing Consumption by Top Countries

9.4.1 Indonesia NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

9.4.2 Thailand NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

9.4.3 Singapore NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

9.4.4 Malaysia NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

9.4.5 Philippines NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

9.4.6 Vietnam NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

9.4.7 Myanmar NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

Chapter 10 Middle East NGS-based RNA-sequencing Market Analysis

10.1 Middle East NGS-based RNA-sequencing Consumption and Value Analysis

10.1.1 Middle East NGS-based RNA-sequencing Market Under COVID-19

10.2 Middle East NGS-based RNA-sequencing Consumption Volume by Types

10.3 Middle East NGS-based RNA-sequencing Consumption Structure by Application

10.4 Middle East NGS-based RNA-sequencing Consumption by Top Countries

10.4.1 Turkey NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

10.4.3 Iran NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

10.4.5 Israel NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

10.4.6 Iraq NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

10.4.7 Qatar NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

10.4.8 Kuwait NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

10.4.9 Oman NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

Chapter 11 Africa NGS-based RNA-sequencing Market Analysis

11.1 Africa NGS-based RNA-sequencing Consumption and Value Analysis

11.1.1 Africa NGS-based RNA-sequencing Market Under COVID-19

11.2 Africa NGS-based RNA-sequencing Consumption Volume by Types

11.3 Africa NGS-based RNA-sequencing Consumption Structure by Application

11.4 Africa NGS-based RNA-sequencing Consumption by Top Countries

11.4.1 Nigeria NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

11.4.2 South Africa NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

11.4.3 Egypt NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

11.4.4 Algeria NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

11.4.5 Morocco NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

Chapter 12 Oceania NGS-based RNA-sequencing Market Analysis

12.1 Oceania NGS-based RNA-sequencing Consumption and Value Analysis

12.2 Oceania NGS-based RNA-sequencing Consumption Volume by Types

12.3 Oceania NGS-based RNA-sequencing Consumption Structure by Application

12.4 Oceania NGS-based RNA-sequencing Consumption by Top Countries

12.4.1 Australia NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

12.4.2 New Zealand NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

Chapter 13 South America NGS-based RNA-sequencing Market Analysis

13.1 South America NGS-based RNA-sequencing Consumption and Value Analysis

13.1.1 South America NGS-based RNA-sequencing Market Under COVID-19

13.2 South America NGS-based RNA-sequencing Consumption Volume by Types

13.3 South America NGS-based RNA-sequencing Consumption Structure by Application

13.4 South America NGS-based RNA-sequencing Consumption Volume by Major Countries

13.4.1 Brazil NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

13.4.2 Argentina NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

13.4.3 Columbia NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

13.4.4 Chile NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

13.4.5 Venezuela NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

13.4.6 Peru NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

13.4.8 Ecuador NGS-based RNA-sequencing Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in NGS-based RNA-sequencing Business

14.1 Illumina

14.1.1 Illumina Company Profile

14.1.2 Illumina NGS-based RNA-sequencing Product Specification

14.1.3 Illumina NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Eurofins Scientific

14.2.1 Eurofins Scientific Company Profile

14.2.2 Eurofins Scientific NGS-based RNA-sequencing Product Specification

14.2.3 Eurofins Scientific NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Agilent Technologies

14.3.1 Agilent Technologies Company Profile

14.3.2 Agilent Technologies NGS-based RNA-sequencing Product Specification

14.3.3 Agilent Technologies NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Thermo Fischer Scientific

14.4.1 Thermo Fischer Scientific Company Profile

14.4.2 Thermo Fischer Scientific NGS-based RNA-sequencing Product Specification

14.4.3 Thermo Fischer Scientific NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 QIAGEN

14.5.1 QIAGEN Company Profile

14.5.2 QIAGEN NGS-based RNA-sequencing Product Specification

14.5.3 QIAGEN NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Oxford Nanopore

14.6.1 Oxford Nanopore Company Profile

14.6.2 Oxford Nanopore NGS-based RNA-sequencing Product Specification

14.6.3 Oxford Nanopore NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Takara Bio

14.7.1 Takara Bio Company Profile

14.7.2 Takara Bio NGS-based RNA-sequencing Product Specification

14.7.3 Takara Bio NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 PerkinElmer

14.8.1 PerkinElmer Company Profile

14.8.2 PerkinElmer NGS-based RNA-sequencing Product Specification

14.8.3 PerkinElmer NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 BGI

14.9.1 BGI Company Profile

14.9.2 BGI NGS-based RNA-sequencing Product Specification

14.9.3 BGI NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Roche

14.10.1 Roche Company Profile

14.10.2 Roche NGS-based RNA-sequencing Product Specification

14.10.3 Roche NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Tecan Genomics

14.11.1 Tecan Genomics Company Profile

14.11.2 Tecan Genomics NGS-based RNA-sequencing Product Specification

14.11.3 Tecan Genomics NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 GENEWIZ

14.12.1 GENEWIZ Company Profile

14.12.2 GENEWIZ NGS-based RNA-sequencing Product Specification

14.12.3 GENEWIZ NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Zymo Research

14.13.1 Zymo Research Company Profile

14.13.2 Zymo Research NGS-based RNA-sequencing Product Specification

14.13.3 Zymo Research NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.14 Hamilton

14.14.1 Hamilton Company Profile

14.14.2 Hamilton NGS-based RNA-sequencing Product Specification

14.14.3 Hamilton NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.15 Macrogen

14.15.1 Macrogen Company Profile

14.15.2 Macrogen NGS-based RNA-sequencing Product Specification

14.15.3 Macrogen NGS-based RNA-sequencing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global NGS-based RNA-sequencing Market Forecast (2022-2027)

15.1 Global NGS-based RNA-sequencing Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global NGS-based RNA-sequencing Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global NGS-based RNA-sequencing Value and Growth Rate Forecast (2022-2027)

15.2 Global NGS-based RNA-sequencing Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global NGS-based RNA-sequencing Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global NGS-based RNA-sequencing Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America NGS-based RNA-sequencing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia NGS-based RNA-sequencing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe NGS-based RNA-sequencing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia NGS-based RNA-sequencing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia NGS-based RNA-sequencing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East NGS-based RNA-sequencing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa NGS-based RNA-sequencing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania NGS-based RNA-sequencing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America NGS-based RNA-sequencing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global NGS-based RNA-sequencing Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global NGS-based RNA-sequencing Consumption Forecast by Type (2022-2027)

15.3.2 Global NGS-based RNA-sequencing Revenue Forecast by Type (2022-2027)

15.3.3 Global NGS-based RNA-sequencing Price Forecast by Type (2022-2027)

15.4 Global NGS-based RNA-sequencing Consumption Volume Forecast by Application (2022-2027)

15.5 NGS-based RNA-sequencing Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology



OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539